Produkty 200871-84-7

CAS 200871-84-7 występuje w naszej ofercie pod nazwami: Boc-d-his(3-me)-oh, 95%, (R)-2-((tert-Butoxycarbonyl)amino)-3-(1-methyl-1H-imidazol-5-yl)propanoic acid, 97%, Boc–D–His(3–Me)–OH, Boc-D-His(3-Me)-OH. Oferty producentów: Combi-blocks, AmBeed, GLPBio, Iris Biotech. Dostępne opakowania: 250mg, 1g, 100mg, 50mg, 5g.

Boc-d-his(3-me)-oh, 95%
Combi-blocks
  • opakowanie: 250mg, 1g, 100mg
  • Warianty: 3
Zobacz produkt
(R)-2-((tert-Butoxycarbonyl)amino)-3-(1-methyl-1H-imidazol-5-yl)propanoic acid, 97%
AmBeed
  • opakowanie: 1g, 50mg
  • Warianty: 2
od 1476,16
Zobacz produkt
Boc–D–His(3–Me)–OH
GLPBio
  • opakowanie: 1g, 250mg
  • Warianty: 2
od 2019,91
Zobacz produkt
Boc-D-His(3-Me)-OH
Iris Biotech
  • opakowanie: 1g, 5g
  • Warianty: 2
od 3370,40
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2R)-3-(3-methylimidazol-4-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid (CAS 200871-84-7) to związek chemiczny o wzorze sumarycznym C12H19N3O4 i masie molowej 269.30 g/mol. Nazwa systematyczna IUPAC: (2R)-3-(3-methylimidazol-4-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid. InChIKey: BGZFLUIZBZNCTI-SECBINFHSA-N.

Dane identyfikacyjne
Wzór sumarycznyC12H19N3O4
Masa molowa269.30 g/mol
Nazwa IUPAC(2R)-3-(3-methylimidazol-4-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
InChIKeyBGZFLUIZBZNCTI-SECBINFHSA-N
SMILESCC(C)(C)OC(=O)N[C@H](CC1=CN=CN1C)C(=O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (R)-2-((tert-Butoxycarbonyl)amino)-3-(1-methyl-1H-imidazol-5-yl)propanoic acid, Boc-D His(pi-Me)-OH, D-Histidine, N-[(1,1-dimethylethoxy)carbonyl]-3-methyl-, N-(tert-Butoxycarbonyl)-3-methyl-D-histidine, N-[(1,1-dimethylethoxy)carbonyl]-3-methyl-d-histidine, (2R)-2-(tert-butoxycarbonylamino)-3-(3-methylimidazol-4-yl)propanoic acid
Powiązane formy tego związku
(2S)-3-(3-methylimidazol-4-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid C12H19N3O4
3-(3-methylimidazol-4-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid C12H19N3O4
Izomery (ten sam wzór sumaryczny)
2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-(1-methylpyrazol-4-yl)acetic acid C12H19N3O4
(2S)-3-(1-methylimidazol-4-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid C12H19N3O4
(2R)-3-(1-methylimidazol-4-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid C12H19N3O4
tert-butyl 2,4-dioxo-1,3,9-triazaspiro[4.5]decane-9-carboxylate C12H19N3O4
(2R)-2-(1-ethylpyrazol-4-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid C12H19N3O4
(2S)-2-(1-ethylpyrazol-4-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid C12H19N3O4
methyl 3-(2-acetyl-6-oxo-2,5-diazaspiro[3.4]octan-7-yl)-2-aminopropanoate C12H19N3O4
4-(dimethylamino)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one C12H19N3O4
tert-butyl 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate C12H19N3O4
2-methyl-2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]pyrazol-1-yl]propanoic acid C12H19N3O4